These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30668520)

  • 21. Resting echocardiographic features of latent left ventricular outflow obstruction in hypertrophic cardiomyopathy.
    Nakatani S; Marwick TH; Lever HM; Thomas JD
    Am J Cardiol; 1996 Sep; 78(6):662-7. PubMed ID: 8831401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction.
    Vogel-Claussen J; Santaularia Tomas M; Newatia A; Boyce D; Pinheiro A; Abraham R; Abraham T; Bluemke DA
    J Magn Reson Imaging; 2012 Sep; 36(3):598-603. PubMed ID: 22549972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study.
    Qin JX; Shiota T; Lever HM; Rubin DN; Bauer F; Kim YJ; Sitges M; Greenberg NL; Drinko JK; Martin M; Agler DA; Thomas JD
    J Am Coll Cardiol; 2002 Jan; 39(2):308-14. PubMed ID: 11788224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience.
    Kotkar KD; Said SM; Dearani JA; Schaff HV
    Ann Cardiothorac Surg; 2017 Jul; 6(4):329-336. PubMed ID: 28944173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
    Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular outflow tract obstruction caused by massive mitral annular calcification in a patient with hypertensive heart disease.
    Yoshida N; Miyoshi T; Ninomaru T; Nagamatsu Y; Tamada N; Hiranuma N; Sasaki Y; Kitamura A; Kanda G; Kobayashi N; Nakagiri K; Fujii T
    J Cardiol Cases; 2015 Sep; 12(3):87-90. PubMed ID: 30524546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mechanisms of mitral regurgitation in hypertrophic cardiomyopathy: A clinical case and literature review.
    Molisana M; Selimi A; Gizzi G; D'Agostino S; Ianni U; Parato VM
    Front Cardiovasc Med; 2022; 9():1020054. PubMed ID: 36386345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of dynamic left ventricular outflow tract obstruction by dobutamine stress echocardiography].
    Bolca O; Dağdeviren B; Eren M; Ozer N; Yildirim A; Tezel T
    Anadolu Kardiyol Derg; 2001 Sep; 1(3):140-5; AXIV. PubMed ID: 12101817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
    Monda E; Lioncino M; Palmiero G; Franco F; Rubino M; Cirillo A; Verrillo F; Fusco A; Caiazza M; Mazzella M; Moscarella E; Dongiglio F; Sepe J; Pacileo G; Calabrò P; Limongelli G
    Int J Cardiol; 2022 May; 354():22-28. PubMed ID: 35278578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant left ventricular outflow tract obstruction secondary to systolic anterior motion in a patient without hypertrophic cardiomyopathy: An echocardiographic study.
    Alrammah H; Ghazal S
    J Saudi Heart Assoc; 2018 Oct; 30(4):336-339. PubMed ID: 30100681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gradient variability in hypertrophic cardiomyopathy: New insights from computer-assisted, high fidelity, rest and exercise hemodynamic analysis.
    Bauch TD; Smith AJ; Murgo JP; Watts JA; Rubal BJ
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):E37-E43. PubMed ID: 30474252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provocation of left ventricular outflow tract obstruction using nitrate inhalation in hypertrophic cardiomyopathy: Relation to electromechanical delay.
    Badran HM; Ibrahim WA; Faheem N; Yassin R; Alashkar T; Yacoub M
    Glob Cardiol Sci Pract; 2015; 2015():15. PubMed ID: 26779503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of Systolic Anterior Motion in Progressive Hypertrophic Cardiomyopathy.
    Koren O; Ehrenberg S; Bloch L; Rozner E; Turgeman Y; Naddaf S
    Am J Case Rep; 2021 Apr; 22():e931359. PubMed ID: 33914716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Left Ventricular Outflow Gradients During Staged Exercise Stress Echocardiography Helps Differentiate Pediatric Patients With Hypertrophic Cardiomyopathy From Athletes and Normal Subjects.
    Gaitonde M; Jones S; McCracken C; Ferguson ME; Michelfelder E; Sachdeva R; Border W
    Pediatr Exerc Sci; 2021 Jul; 33(4):196-202. PubMed ID: 34303306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.
    Güçlü A; Happé C; Eren S; Korkmaz IH; Niessen HW; Klein P; van Slegtenhorst M; Schinkel AF; Michels M; van Rossum AC; Germans T; van der Velden J
    Eur J Clin Invest; 2015 Dec; 45(12):1252-9. PubMed ID: 26444145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac MR Tissue Tracking.
    She JQ; Guo JJ; Yu YF; Zhao SH; Chen YY; Ge MY; Zeng MS; Jin H
    J Magn Reson Imaging; 2021 Jan; 53(1):51-60. PubMed ID: 32798304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of basal septal hypertrophy: From benign and age-related normal variant to potentially obstructive and symptomatic cardiomyopathy.
    Pearson AC
    Echocardiography; 2017 Jul; 34(7):1062-1072. PubMed ID: 28593726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revelation of an obstructive hypertrophic cardiomyopathy in an elderly patient.
    Patanè S; Marte F; Portaro A
    Int J Cardiol; 2010 Nov; 145(2):e41-e43. PubMed ID: 19181403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intraventricular obstructions in dobutamine stress echocardiography: determinants of their development and clinical sequelae].
    Wagner S; Mohr-Kahaly S; Nixdorff U; Kuntz S; Menzel T; Kölsch B; Meinert R; Meyer J
    Z Kardiol; 1997 May; 86(5):327-35. PubMed ID: 9304307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.